India's Serum Institute seeks approval to make Russia's Sputnik V vaccine

  • On top of the AstraZeneca PLC and Novavax Inc shots it is already producing.
03 Jun, 2021

NEW DELHI: The Serum Institute of India has sought regulatory approval to make Russia's Sputnik V COVID-19 vaccine, local media reported on Thursday, on top of the AstraZeneca PLC and Novavax Inc shots it is already producing.

Read Comments